The application of virus-like particles to human diseases

Expert Review of Vaccines

Volumn 12, Issue 2, 2013, Pages 99-

  Buonaguro, Franco ^a   Buonaguro, Luigi ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; RECOMBINANT HEPATITIS B VACCINE; VACCINE; WART VIRUS VACCINE;

CLINICAL ASSESSMENT; CLINICAL TRIAL (TOPIC); DRUG FORMULATION; DRUG MANUFACTURE; DRUG SAFETY; EDITORIAL; GENE PRODUCT; HEPATITIS B; HUMAN; IMMUNOGENICITY; NONHUMAN; PAPILLOMAVIRUS INFECTION; POLYOMA VIRUS; PRIORITY JOURNAL; VIRUS ENVELOPE; VIRUS INFECTION; VIRUS LIKE AGENT;

BIOTECHNOLOGY; HUMANS; TECHNOLOGY, PHARMACEUTICAL; VACCINATION; VACCINES, VIRUS-LIKE PARTICLE; VIRAL VACCINES; VIRUS DISEASES;

EID: 84874092031     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.12.154     Document Type: Editorial

References (1)

1. Brady JN, Consigli RA. Chromatographic separation of the polyoma virus proteins and renaturation of the isolated VP1 major capsid protein. J. Virol. 27(2), 436-442 (1978).